Deferred Tax Assets, Net of Valuation Allowance of Neuphoria Therapeutics Inc. from 30 Jun 2023 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Neuphoria Therapeutics Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2023 to 30 Jun 2025.
Neuphoria Therapeutics Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $26,100,000, a 5.8% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$26,100,000	-$1,600,000	-5.8%	30 Jun 2025	10-K	29 Sep 2025	2025	FY
Q2 2024	$27,700,000	+$4,218,550	+18%	30 Jun 2024	10-K	29 Sep 2025	2025	FY
Q2 2023	$23,481,450			30 Jun 2023	10-K	30 Sep 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.